3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Breast
1
Conditions
Breast Neoplasms
3
Triple Negative Breast Neoplasms
1
Neoplasms
1
Meningeal Neoplasms
1
Brain Neoplasms
1
Interventions
patritumab deruxtecan
1
mafosfamide
1
avelumab
1
Topotecan
1
Psychiatric Rehabilitation
1
Cytarabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Meningeal Neoplasms
×
patritumab deruxtecan
×
Clear all
NCT05865990
2026-05-04
TUXEDO-3
MedSIR
Phase 2
Completed
63 enrolled